Rifampicin sparing treatment protocols in posttransplant tuberculosis.
Jha
Vivekanand
V
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. vjha@pginephro.org
Sakhuja
Vinay
V
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000209:etiology
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D012293:Rifampin